Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Longduoduo Company Limited (LDDD) fair value: what the stock is really worth
As of Sep 18, 2026: fair value of Longduoduo Company Limited $0.34, price $0.51, upside -33.3%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? No
- Good quality? Yes
- Add to watchlist
LC
Thin data
Sep 24, 2026
Thin data
Sep 24, 2026
Longduoduo Company Limited
LDDD · USOvervalued / MonitorQuality is not strong enough to offset the price risk.
!Fair value $0.3400 · Overvalued (−33%)
!Quality 57/100
!Mixed Growth (revenue 3y +9.6 %/yr)
!Loss over the last twelve months · -16.5% net margin (TTM) · fiscal year 2025 10.8%
✓generates free cash flow
!Trails peers (1/10)
!Narrow moat 15/100
!Evidence only low, so the estimate is less certain
Watch Longduoduo Company Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
44‑month range $0.5100 – $109.00 · fair‑value band $0.1600 – $0.4200 · the $0.5100 price screens above the $0.3400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Longduoduo Company in your weekly email
Every Wednesday you see whether Longduoduo Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China.
Show more
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.
Stock analysis
Longduoduo Company Limited (LDDD) currently trades at $0.5100, while our model-based Fair Value estimate is $0.3400, implying the stock looks roughly 50.0% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $0.7100 per share, and 8 of the 24 models we run sit above the $0.5100 price.
Bear case: the Economic Profit group reads lowest at $0.1700, and 16 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.1600 (bear) to $0.4200 (bull), the price of $0.5100 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Longduoduo Company Limited reported revenue of $4.3M in FY2025 versus $414K in FY2021, a compound +79.1%/yr. Reported net income was $460K in FY2025.
Key figures
Market cap $15.3M · P/S ratio 7.18 · EPS (TTM) $−0.0100 · Net margin 10.8% · Return on equity −43.1% · Return on assets (EBIT) −237% · Operating margin −105% · Revenue (TTM) $2.1M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 63% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −33%, LDDD screens richer than that median.
Fair Value models
Bear $0.1600
Fair Value $0.3400
Bull $0.4200
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF
$0.1700
$0.2300
$0.4300
71
EPV
$0.1500
$0.1700
$0.1800
70
Growth DCF
$0.1600
$0.2600
$0.4200
69
All 24 models by family
DCF Models
FCF DCF
$0.1700
$0.2300
$0.4300
71
Owner Earnings
$0.3200
$0.6400
$1.30
64
5Y Revenue Exit
$0.2200
$0.3600
$0.6600
62
5Y EBITDA Exit
$0.2700
$0.4500
$0.8200
64
5Y P/E Exit
$0.2700
$0.5800
$1.00
60
10Y Revenue Exit
$0.2000
$0.4200
$0.5700
59
10Y EBITDA Exit
$0.2400
$0.5200
$1.01
57
10Y P/E Exit
$0.2500
$0.5300
$1.02
54
Earnings-Based
Graham-Dodd
$0.1000
$0.7300
$1.02
59
Lynch FV
$0.3800
$0.5400
$0.7000
57
PEG = 1.0
$0.3800
$0.5400
$0.7000
53
EPV
$0.1500
$0.1700
$0.1800
70
Multiples
P/E Multiple
$0.2500
$0.3400
$0.4200
63
P/S Multiple
$0.2000
$0.2600
$0.3300
58
P/B Multiple
$0.1300
$0.1800
$0.2200
55
EV/EBIT
$0.2900
$0.3700
$0.4500
63
EV/EBITDA
$0.3000
$0.3800
$0.4600
64
EV/Revenue
$0.2200
$0.2900
$0.3700
52
Asset-Based
NCAV (Graham)
$0.0200
$0.0300
$0.0400
52
Growth DCF
Growth DCF
$0.1600
$0.2600
$0.4200
69
Rev-Margin DCF
$0.2400
$0.4100
$0.7500
62
Economic Profit
Residual Income
$0.1200
$0.1700
$1.96
53
ROIC Compounder
$0.1500
$0.1700
$0.1800
66
Growth Earnings
Growth-Adj P/E
$0.5000
$0.7100
$0.9300
63
Notify me when LDDD reaches fair value
Put LDDD on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
57/100
Of which business quality 64 · Market factors (momentum, volatility) 20
Profitability
90
Margins and returns on capital today
Quality Growth
10
Are margins and returns improving?
Cashflow
37
Earnings quality: real cash, not paper profit
Fin. Strength
97
Balance sheet, leverage, solvency risk
Investment
50
Disciplined investing over empire-building
Low Volatility
23
Calm price path (market factor)
Momentum
29
Price trend over the last 3–12 months (market factor)
52W Momentum
0
Distance to the 52-week high (market factor)
Net Issuance
82
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
60/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−42.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−91.4% (2021) → 13.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+33.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +29.9% a year for the price.
LDDD screens 50% overvalued. Compare with Thermo Fisher Scientific Inc →
Compare Longduoduo Company Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 143 stocks
Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | $678.39 | $686.04 | +1% |
| Danaher Corporation DHR | $223.77 | $209.18 | −7% |
| WuXi AppTec Co 2359 | HK$207.60 | HK$228.36 | +10% |
| Lonza Group LONN | CHF 570.00 | CHF 151.69 | −73% |
| IDEXX Laboratories, Inc IDXX | $522.02 | $495.84 | −5% |
| Agilent Technologies, Inc A | $165.32 | $63.90 | −61% |
| Waters Corporation WAT | $425.74 | $106.31 | −75% |
| IQVIA Holdings IQV | $270.09 | $295.80 | +10% |
| Illumina, Inc ILMN | $255.38 | $280.92 | +10% |
| Mettler-Toledo International Inc MTD | $1,491 | $635.75 | −57% |
Explore undervalued stocks
More undervalued Healthcare stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Longduoduo Company Limited (LDDD) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.3400 versus the last price from Sep 18, 2026 of $0.5100, about −33% upside (overvalued).
What is the fair value of LDDD?
Our model-based fair value for Longduoduo Company Limited is $0.3400 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Sep 18, 2026): $0.5100.
What is the quality score of LDDD?
Longduoduo Company Limited has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Longduoduo Company Limited (LDDD)?
Our model-based price target is the fair value of $0.3400 (as of Sep 24, 2026) from 24 valuation models. Cautious scenario $0.1600, optimistic scenario $0.4200. It is a calculation from audited fundamentals, not an analyst target.
What is the Longduoduo Company Limited stock forecast for 2026?
Our models put fair value at $0.3400, about −33% upside versus the last price from Sep 18, 2026 of $0.5100 (overvalued). Cautious scenario $0.1600, optimistic scenario $0.4200. The calculation is refreshed regularly with new filings.
What is the revenue of Longduoduo Company Limited (LDDD)?
Longduoduo Company Limited reported trailing-twelve-month revenue of about $2.1M (latest available figure, as of Sep 24, 2026).
What growth is priced into Longduoduo Company Limited (LDDD)?
For today's price to be fair in a discounted-cash-flow model, Longduoduo Company Limited would have to grow free cash flow by +33.0 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +79.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of LDDD use?
Our models discount Longduoduo Company Limited at 10.2 %: a base by market capitalisation (nano), damped by beta 1.20, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Longduoduo Company Limited that is +33.0 % per year a year over ten years, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has Longduoduo Company Limited (LDDD) delivered so far?
Over the past 4 years revenue at Longduoduo Company Limited grew +79.2 % a year. The price currently implies +33.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Longduoduo Company Limited (LDDD) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Longduoduo Company Limited (+33.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Longduoduo Company Limited (LDDD)?
The free-cash-flow yield on the price is 1.42 %: that much free cash flow Longduoduo Company Limited produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Longduoduo Company Limited (LDDD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Longduoduo Company Limited it is $0.3400 per share (as of Sep 24, 2026), against a price of $0.5100. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Longduoduo Company Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, LDDD trades above its calculated fair value: price $0.5100, fair value $0.3400, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LDDD?
No. The price is what the market pays today ($0.5100); the fair value is what the company's own numbers justify ($0.3400). For Longduoduo Company Limited the two are $0.1700 per share apart. That gap is exactly why we show both numbers side by side.
How much is Longduoduo Company Limited worth?
The market values Longduoduo Company Limited at about $15.3M (market capitalisation, as of Sep 24, 2026). Per share that is $0.5100; our models calculate a fair value of $0.3400 per share.
What do the bullish and bearish scenarios say about LDDD?
Our models span a range for Longduoduo Company Limited: cautious scenario $0.1600, base $0.3400, optimistic $0.4200 per share (as of Sep 24, 2026, price $0.5100). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Longduoduo Company Limited (LDDD)?
Balance-sheet figures for Longduoduo Company Limited (as of Sep 24, 2026): return on equity −43.1%. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is LDDD from its 52-week high?
Longduoduo Company Limited trades at $0.5100, about 63% below its 52-week high of $1.37 and at the low of $0.5100 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.3400 is for.
Which stocks are comparable to Longduoduo Company Limited?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Longduoduo Company Limited stock attractive at the current price?
The data as of Sep 24, 2026: price $0.5100, calculated fair value $0.3400 (−33%), Quality Score 57/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LDDD calculated?
We run Longduoduo Company Limited through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.3400, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Longduoduo Company Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Longduoduo Company Limited (LDDD)?
The latest price we hold is from Sep 18, 2026 and stands at $0.5100. Our model-based fair value is $0.3400, about −33% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Longduoduo Company Limited right now?
The price sits above even our optimistic bull case ($0.4200). The favourable scenario is already priced in. The model range is unusually wide ($0.1600 to $0.4200). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Longduoduo Company Limited
How large is the market capitalisation of Longduoduo Company Limited (LDDD)?
The market capitalisation of Longduoduo Company Limited is $15.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Longduoduo Company Limited (LDDD)?
The price-to-sales ratio of Longduoduo Company Limited is 7.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Longduoduo Company Limited (LDDD)?
Earnings per share at Longduoduo Company Limited are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Longduoduo Company Limited (LDDD)?
The net margin of Longduoduo Company Limited is 10.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Longduoduo Company Limited (LDDD)?
The return on equity (ROE) of Longduoduo Company Limited is −43.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Longduoduo Company Limited (LDDD)?
On an EBIT basis the return on assets of Longduoduo Company Limited is −237% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Longduoduo Company Limited (LDDD)?
The operating margin of Longduoduo Company Limited is −105% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Longduoduo Company Limited (LDDD)?
Revenue at Longduoduo Company Limited is growing −75.9% versus a year earlier (3y avg +9.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Longduoduo Company Limited (LDDD)?
Earnings per share at Longduoduo Company Limited are growing −47.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Longduoduo Company Limited (LDDD) hold?
Longduoduo Company Limited holds more cash than debt, $1.6M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Longduoduo Company Limited in the live analysis
One click puts Longduoduo Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.